Hepatitis C and Renal Transplantation in the Era of New Antiviral Agents

116.1 - Hepatitis C and Renal Transplantation in the Era of New Antiviral Agents

Presenter: José Maria, Morales, Madrid, Spain
Authors: José Maria Morales


Jose M Morales is Professor of Medicine and currently Consultant Investigator in the Research Institute of Hospital 12 de Octubre of Madrid, Spain. He is Past-President of the Madrid Transplantation Society and Past- Chief of Renal Transplant Program in Hospital 12 de Octubre. His main clinical and investigational activity has been focused on renal transplantation, especially Hepatitis C and immunosuppression, publishing more than 250 peer-review papers (H-index 38). He is a member of the experts who developed the KDIGO guidelines for Hepatitis C in chronic kidney disease in 2008 and 2017. He is the Vice-Chair of the 27th Congress of the Transplantation Society that will be held in Madrid 30 June-5 July, 2018.


Hepatitis C infection after renal transplantation can induce severe liver disease and lower patient and graft survival in HCV-infected compared with HCV negative patients. The successful use of new direct-acting antivirals for hepatitis C is changing the landscape of this complication in renal transplant patients. Therefore, if these drugs become available for all patients and their use is not restricted by the cost, probably Hepatitis C will not be a problem and will show excellent results after renal transplantation worldwide.

You must be logged in to view recordings

Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.